Gastrointestinal Bleeding Due to NOACs Use: Exploring the Molecular Mechanisms

Novel oral anticoagulants (NOACs) are drugs approved for the prevention and treatment of many thromboembolic cardiovascular conditions as a safer alternative to warfarin. We reviewed studies published in PubMed(®), UpToDate(®), Web of Science(®), and Cochrane(®) about NOACs’ risks and benefits in pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Saviano, Angela, Brigida, Mattia, Petruzziello, Carmine, Candelli, Marcello, Gabrielli, Maurizio, Ojetti, Veronica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698754/
https://www.ncbi.nlm.nih.gov/pubmed/36430433
http://dx.doi.org/10.3390/ijms232213955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698754/
https://www.ncbi.nlm.nih.gov/pubmed/36430433
http://dx.doi.org/10.3390/ijms232213955

Ejemplares similares